UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029254
Receipt number R000031781
Scientific Title Peripheral Intravenous Cannulation Outcome with the use of topical anaesthesia in pediatric emergency department in Japan: A prospective observational study
Date of disclosure of the study information 2017/09/22
Last modified on 2021/03/29 15:45:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Peripheral Intravenous Cannulation Outcome with the use of topical anaesthesia in pediatric emergency department in Japan: A prospective observational study

Acronym

PICO Study

Scientific Title

Peripheral Intravenous Cannulation Outcome with the use of topical anaesthesia in pediatric emergency department in Japan: A prospective observational study

Scientific Title:Acronym

PICO Study

Region

Japan


Condition

Condition

Healthy Children who presented in the ED

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the success rate of peripheral intravenous insertion with the use of lidocaine patch.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

The success rate of peripheral intravenous insertion with the use of lidocaine patch.

Key secondary outcomes

1 Success rate between peripheral intravenous insertion with lidocaine patch and without lidocaine patch in the previous trial (UMIN000014730)
2 Duration of lidocaine patch attachment and success rate
3 The pain scale and success rate
4 The pain scale with/without lidocaine patch
5 The pain scale and duration of lidocaine patch attachment
6 Success rate and person's experience as a pediatrician


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

16 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients who visited the ED from 9 AM to 5 PM through Monday to Friday (National holiday excluded).
2. Patients who are less than 16 years old.
3. Patients Who's intravenous access is warranted and senior residents attempted the initial procedure.

Key exclusion criteria

1. Evaluated as "blue triage" based on JTAS triage system or similar conditions at the initial encounter.
(unstable breathing or circulation in need of emergent intervention)
2. The doctor in charge of the study or the doctors in alliance with the study decide ineligible to participate in the study.
3. Patients or the guardians who were unwilling to participate in the study.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Hataya

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Department of General Pediatrics

Zip code

183-8561

Address

2-8-29 Mushashidai, Fuchu-city, Tokyo, Japan

TEL

042-300-5111

Email

hiroshi_hataya@tmhp.jp


Public contact

Name of contact person

1st name Osamu
Middle name
Last name Matumura

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Department of General Pediatrics

Zip code

183-8561

Address

2-8-29 Mushashidai, Fuchu-city, Tokyo, Japan

TEL

042-300-5111

Homepage URL


Email

osamupineville@gmail.com


Sponsor or person

Institute

Tokyo Metropolitan Children's Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Metropolitan Government

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Metropolitan Children's Medical Center

Address

2-8-29 Mushashidai, Fuchu-city, Tokyo, Japan

Tel

042-300-5111

Email

osamupineville@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京都立小児総合医療センター
Tokyo Metropolitan Children’s Medical Center


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 22 Day


Related information

URL releasing protocol

None

Publication of results

Unpublished


Result

URL related to results and publications

None

Number of participants that the trial has enrolled

520

Results

383 patients used topical anesthesia while 96 patients didn't. The success rate of first intravenous catheterization insertion was 77.3% in the topical anesthesia group while placebo group's success rate was 67.7%.
The underlying disease, years of experience, the use of LED transilluminator, and the presence of hand motion was adjusted in the comparison analysis. The comparison analysis showed OR 2.0 (95%CI 1.1-3.7) in the topical anesthesia group compared to placebo group.

Results date posted

2021 Year 03 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 08 Month 21 Day

Baseline Characteristics

All patients who are less than 16 years old in need of intravenous catheterization.
Patients who are
1. Evaluated as "blue triage" based on JTAS triage system or similar conditions at the initial encounter.
(unstable breathing or circulation in need of emergent intervention)
2. The doctor in charge of the study or the doctors in alliance with the study decide ineligible to participate in the study.
3. Patients or the guardians who were unwilling to participate in the study.
4. Patients who are allergic to lidocaine (topical anesthesia),
5. Patients who are difficult to use topical anesthesia due to skin condition were excluded.
were excluded.

Participant flow

Patients who came to the ER from 9:00-17:00 Monday through Friday and in need of intravenous catheterization were asked for topical anesthesia use procedure before catheterization. The success rate of 1st attempt intravenous catheterization were analyzed.

Adverse events

One patient's topical anesthesia were accidently put on the clothes instead of the skin.

Outcome measures

The success rate of intravenous catheterization

Plan to share IPD

None

IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 23 Day

Date of IRB

2017 Year 10 Month 25 Day

Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date

2018 Year 09 Month 30 Day

Date of closure to data entry

2019 Year 03 Month 14 Day

Date trial data considered complete

2019 Year 03 Month 14 Day

Date analysis concluded

2020 Year 09 Month 27 Day


Other

Other related information

None to be noted


Management information

Registered date

2017 Year 09 Month 22 Day

Last modified on

2021 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031781


Research Plan
Registered date File name
2021/03/29 研究実施計画書_編集履歴削除版.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name